Liverpool mother pleads guilty to 1998 manslaughter of newborn baby, case reopened after DNA breakthrough.
FDA nominee faces intense questioning on mifepristone safety and vaccine advisory meeting cancellation, raising concerns over data-driven policy decisions.
Liverpool mother pleads guilty to 1998 manslaughter of newborn baby, case reopened after DNA breakthrough.
FDA nominee faces intense questioning on mifepristone safety and vaccine advisory meeting cancellation, raising concerns over data-driven policy decisions.